vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与TFS Financial CORP（TFSL）财务数据对比。点击上方公司名可切换其他公司
TFS Financial CORP的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.1倍（$83.7M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 11.9%），TFS Financial CORP自由现金流更多（$57.1M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 4.2%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
TFS金融公司是一家总部位于美国的金融控股企业，主要通过旗下零售银行子公司开展业务，提供住房抵押贷款、储蓄账户及其他消费金融产品，核心客群主要分布于俄亥俄州和佛罗里达州，以个人及家庭客户为服务重心。
PBYI vs TFSL — 直观对比
营收规模更大
TFSL
是对方的1.1倍
$75.5M
营收增速更快
PBYI
高出15.8%
11.9%
自由现金流更多
TFSL
多$42.7M
$14.4M
两年增速更快
PBYI
近两年复合增速
4.2%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $83.7M |
| 净利润 | — | $22.3M |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | 34.0% |
| 净利率 | — | 26.6% |
| 营收同比 | 27.7% | 11.9% |
| 净利润同比 | — | -0.7% |
| 每股收益（稀释后） | $0.26 | $0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYITFSL
| Q4 25 | $75.5M | $83.7M | ||
| Q3 25 | $54.5M | $85.5M | ||
| Q2 25 | $52.4M | $82.0M | ||
| Q1 25 | $46.0M | $79.1M | ||
| Q4 24 | $59.1M | $74.8M | ||
| Q3 24 | $80.5M | $75.1M | ||
| Q2 24 | $47.1M | $75.5M | ||
| Q1 24 | $43.8M | $77.1M |
净利润PBYITFSL
| Q4 25 | — | $22.3M | ||
| Q3 25 | $8.8M | $26.0M | ||
| Q2 25 | $5.9M | $21.5M | ||
| Q1 25 | $3.0M | $21.0M | ||
| Q4 24 | — | $22.4M | ||
| Q3 24 | $20.3M | $18.2M | ||
| Q2 24 | $-4.5M | $20.0M | ||
| Q1 24 | $-4.8M | $20.7M |
毛利率PBYITFSL
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
营业利润率PBYITFSL
| Q4 25 | 22.7% | 34.0% | ||
| Q3 25 | 17.6% | 37.9% | ||
| Q2 25 | 12.7% | 33.3% | ||
| Q1 25 | 8.7% | 33.5% | ||
| Q4 24 | 22.6% | 37.9% | ||
| Q3 24 | 27.4% | 30.7% | ||
| Q2 24 | -4.6% | 33.4% | ||
| Q1 24 | -5.3% | 33.6% |
净利率PBYITFSL
| Q4 25 | — | 26.6% | ||
| Q3 25 | 16.2% | 30.4% | ||
| Q2 25 | 11.2% | 26.2% | ||
| Q1 25 | 6.5% | 26.6% | ||
| Q4 24 | — | 30.0% | ||
| Q3 24 | 25.2% | 24.2% | ||
| Q2 24 | -9.6% | 26.4% | ||
| Q1 24 | -11.0% | 26.9% |
每股收益（稀释后）PBYITFSL
| Q4 25 | $0.26 | $0.08 | ||
| Q3 25 | $0.17 | $0.09 | ||
| Q2 25 | $0.12 | $0.08 | ||
| Q1 25 | $0.06 | $0.07 | ||
| Q4 24 | $0.40 | $0.08 | ||
| Q3 24 | $0.41 | $0.07 | ||
| Q2 24 | $-0.09 | $0.07 | ||
| Q1 24 | $-0.10 | $0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $456.7M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $1.9B |
| 总资产 | $216.3M | $17.5B |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYITFSL
| Q4 25 | $97.5M | $456.7M | ||
| Q3 25 | $94.4M | $429.4M | ||
| Q2 25 | $96.0M | $452.6M | ||
| Q1 25 | $93.2M | $463.6M | ||
| Q4 24 | $101.0M | $465.9M | ||
| Q3 24 | $96.7M | $463.7M | ||
| Q2 24 | $96.8M | $560.4M | ||
| Q1 24 | $107.2M | $594.3M |
总债务PBYITFSL
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYITFSL
| Q4 25 | $130.3M | $1.9B | ||
| Q3 25 | $115.3M | $1.9B | ||
| Q2 25 | $104.7M | $1.9B | ||
| Q1 25 | $97.1M | $1.9B | ||
| Q4 24 | $92.1M | $1.9B | ||
| Q3 24 | $71.1M | $1.9B | ||
| Q2 24 | $48.5M | $1.9B | ||
| Q1 24 | $51.0M | $1.9B |
总资产PBYITFSL
| Q4 25 | $216.3M | $17.5B | ||
| Q3 25 | $202.9M | $17.5B | ||
| Q2 25 | $194.9M | $17.4B | ||
| Q1 25 | $196.2M | $17.1B | ||
| Q4 24 | $213.3M | $17.1B | ||
| Q3 24 | $220.7M | $17.1B | ||
| Q2 24 | $205.0M | $17.0B | ||
| Q1 24 | $214.1M | $17.0B |
负债/权益比PBYITFSL
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $58.7M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $57.1M |
| 自由现金流率自由现金流/营收 | 19.1% | 68.2% |
| 资本支出强度资本支出/营收 | 0.0% | 2.0% |
| 现金转化率经营现金流/净利润 | — | 2.64× |
| 过去12个月自由现金流最近4个季度 | $41.7M | $167.4M |
8季度趋势，按日历期对齐
经营现金流PBYITFSL
| Q4 25 | $14.4M | $58.7M | ||
| Q3 25 | $9.7M | $82.4M | ||
| Q2 25 | $14.1M | $26.8M | ||
| Q1 25 | $3.6M | $21.2M | ||
| Q4 24 | $15.6M | $45.5M | ||
| Q3 24 | $11.0M | $88.6M | ||
| Q2 24 | $1.0M | $96.7M | ||
| Q1 24 | $11.2M | $14.2M |
自由现金流PBYITFSL
| Q4 25 | $14.4M | $57.1M | ||
| Q3 25 | $9.7M | $71.0M | ||
| Q2 25 | $14.1M | $25.0M | ||
| Q1 25 | $3.6M | $14.3M | ||
| Q4 24 | $15.6M | $44.9M | ||
| Q3 24 | $11.0M | $85.5M | ||
| Q2 24 | $1.0M | $95.9M | ||
| Q1 24 | — | $13.4M |
自由现金流率PBYITFSL
| Q4 25 | 19.1% | 68.2% | ||
| Q3 25 | 17.7% | 83.0% | ||
| Q2 25 | 26.8% | 30.5% | ||
| Q1 25 | 7.7% | 18.0% | ||
| Q4 24 | 26.4% | 60.0% | ||
| Q3 24 | 13.7% | 113.8% | ||
| Q2 24 | 2.1% | 127.0% | ||
| Q1 24 | — | 17.4% |
资本支出强度PBYITFSL
| Q4 25 | 0.0% | 2.0% | ||
| Q3 25 | 0.0% | 13.4% | ||
| Q2 25 | 0.0% | 2.1% | ||
| Q1 25 | 0.1% | 8.8% | ||
| Q4 24 | 0.0% | 0.9% | ||
| Q3 24 | 0.0% | 4.1% | ||
| Q2 24 | 0.0% | 1.1% | ||
| Q1 24 | 0.0% | 1.1% |
现金转化率PBYITFSL
| Q4 25 | — | 2.64× | ||
| Q3 25 | 1.10× | 3.17× | ||
| Q2 25 | 2.41× | 1.24× | ||
| Q1 25 | 1.21× | 1.01× | ||
| Q4 24 | — | 2.03× | ||
| Q3 24 | 0.54× | 4.86× | ||
| Q2 24 | — | 4.85× | ||
| Q1 24 | — | 0.69× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
